adg106
Showing 1 - 4 of 4
Solid Tumor, Non-Hodgkin Lymphoma Trial in Guangzhou, Shanghai (ADG106)
Active, not recruiting
- Solid Tumor
- Non-Hodgkin Lymphoma
- ADG106
-
Guangzhou, Guangdong, China
- +1 more
Oct 15, 2022
HER2-negative Breast Cancer, Advanced Solid Tumor Trial in Singapore (ADG106, Doxorubicin, Cyclophosphamide)
Recruiting
- HER2-negative Breast Cancer
- Advanced Solid Tumor
- ADG106
- +3 more
-
Singapore, SingaporeNational University Hospital
Jun 9, 2022
Metastatic Non Small Cell Lung Cancer Trial in Singapore (Nivolumab, ADG106)
Recruiting
- Metastatic Non Small Cell Lung Cancer
- Nivolumab
- ADG106
-
Singapore, Singapore
- +1 more
Mar 10, 2022